ACR 36: Parkinson’s Disease Awareness Month.
- Session Year: 2019-2020
- House: Assembly
- Latest Version Date: 2019-05-15
|
Date
|
Status
|
|---|---|
| May 15, 2019 | Chaptered by Secretary of State - Res. Chapter 52, Statutes of 2019. |
| May 15, 2019 | Enrolled and filed with the Secretary of State at 2:45 p.m. |
| May 9, 2019 | In Assembly. Ordered to Engrossing and Enrolling. |
| May 9, 2019 | Adopted and to Assembly. |
| May 6, 2019 | Ordered to special consent calendar. |
| May 1, 2019 | From committee: Ordered to third reading. |
| Apr 22, 2019 | In Senate. To Com. on RLS. |
| Apr 11, 2019 | Coauthors revised. |
| Apr 4, 2019 | From committee: Be adopted. Ordered to Third Reading. (Ayes 9. Noes 0.) (April 4). |
| Feb 28, 2019 | Referred to Com. on RLS. |
| Feb 22, 2019 | From printer. |
| Feb 21, 2019 | Introduced. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| May 9, 2019 | Special Consent ACR36 | Senate Floor |
Passed |
|
| Apr 4, 2019 | Be adopted. To third reading. | Assembly Standing Committee on Rules |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | ACR 36 |
THIRD READING
Bill No: ACR 36
Introduced: 2/21/19
ASSEMBLY FLOOR: Read and adopted, 4/11/19
SUBJECT: Parkinson’s Disease Awareness Month
DIGEST:
This resolution designates April 2019 as Parkinson’s Disease Awareness Month.
ANALYSIS: This resolution makes the following legislative findings:
- Parkinson’s disease is a chronic, progressive neurological disease that is the second most common neurodegenerative disease in the United States.
- It is estimated that over 1.5 million people in the United States suffer from Parkinson’s disease, with 70,000 newly diagnosed cases per year.
- Parkinson’s disease is the 14th leading cause of death in the United States and is estimated to cost the country at least $14.4 billion annually.
- Parkinson’s disease is caused by both genetic and environmental factors; and there is no diagnostic biomarker for Parkinson’s disease and the rate of misdiagnosis can be high.
- The symptoms of Parkinson’s vary from person to person and can include tremor, rigidity, slowness of movement; difficulty with balance, swallowing, chewing, and speaking; and cognitive dysfunction, including dementia, depression, anxiety disorder, insomnia, and attention difficulties.
- There is no cure, therapy, or drug to slow or stop the progression of Parkinson’s disease, with disease progression leading to severe disability and possible confinement to a wheelchair or a bed.
- Increased education and promoting research is needed to find the cause, more effective treatment, and a cure for Parkinson’s disease.
- Better awareness and expanded knowledge of the realities of life with Parkinson’s disease will allow the community at large to better support people who struggle with the challenges of this debilitating condition.
- The community’s focus on Parkinson’s disease and its impact on patients’ lives will help give hope for a better future for people with Parkinson’s disease.
This resolution designates the month of April 2019, as Parkinson’s Disease Awareness Month, and urges all citizens to support the search for a cure and to assist those individuals and families who deal with this disabling disease on a daily basis.
Related/Prior Legislation
HR 45 (Dababneh, 2016) proclaimed the month of April 2016 as Parkinson’s Disease Awareness Month in California and urged all citizens to support the search for a cure and to assist those individuals and families who deal with this disabling disease on a daily basis. Adopted by the Assembly on May 5, 2016.
ACR 139 (Ridley-Thomas, Resolution Chapter 50, Statutes of 2014) designated the month of April 2014 as Parkinson’s Disease Awareness Month.
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
None received
OPPOSITION: (Verified 4/29/19)
None received
Prepared by: Melissa Ward / SFA / (916) 651-1520
5/1/19 16:17:38
ASSEMBLY THIRD READING
ATR Bill Id:ACR 36
Author:(Nazarian)
As Introduced Ver:February 21, 2019
Majority vote
SUMMARY:
Designates April 2019 as Parkinson's Disease Awareness Month. Specifically, this resolution makes the following legislative findings:
- Parkinson's disease is a chronic, progressive neurological disease that is the second most common neurodegenerative disease in the United States. It is estimated that over 1.5 million people in the United States suffer from Parkinson's disease, with 70,000 newly diagnosed cases per year.
- Parkinson's disease is the 14th leading cause of death in the United States and is estimated to cost the country at least $14.4 billion annually.
- The symptoms of Parkinson's vary from person to person and can include tremor, rigidity, slowness of movement; difficulty with balance, swallowing, chewing, and speaking; and cognitive dysfunction, including dementia, depression, anxiety disorder, insomnia, and attention difficulties.
- There is no cure, therapy, or drug to slow or stop the progression of Parkinson's disease, with disease progression leading to severe disability and possible confinement to a wheelchair or bed.
- Local, regional, and state volunteers, researchers, and clinicians are working together to improve the quality of life of the affected individuals with Parkinson's disease and their families. Increased education and promoting research is needed to find the cause, more effective treatment, and a cure for Parkinson's disease.
- Better awareness and expanded knowledge of the realities of life with Parkinson's disease and its impact on patients' lives will help give hope for a better future for people with Parkinson's disease.
Major Provisions
None
COMMENTS:
None
According to the Author:
None
Arguments in Support:
None
Arguments in Opposition:
None
FISCAL COMMENTS:
No fiscal impact
VOTES:
ASM RULES: 9-0-3
YES: Cooley, Flora, Grayson, Kamlager-Dove, Maienschein, Mathis, Ramos, Robert Rivas, Wicks
ABS, ABST OR NV: Cunningham, Carrillo, Quirk-Silva
UPDATED:
VERSION: February 21, 2019
CONSULTANT: Nicole Willis / RLS. / (916) 319-2800 FN: 0000105
Date of Hearing: April 4, 2019
ASSEMBLY COMMITTEE ON RULES
Ken Cooley, Chair
ABPCA Bill Id:ACR 36 (
Author:Nazarian) – As Introduced Ver:February 21, 2019
SUBJECT: Parkinson’s Disease Awareness Month.
SUMMARY: Designates April 2019 as Parkinson’s Disease Awareness Month. Specifically, this resolution makes the following legislative findings:
- Parkinson’s disease is a chronic, progressive neurological disease that is the second most common neurodegenerative disease in the United States. It is estimated that over 1.5 million people in the United States suffer from Parkinson’s disease, with 70,000 newly diagnosed cases per year.
- Parkinson’s disease is the 14th leading cause of death in the United States and is estimated to cost the country at least $14.4 billion annually.
- The symptoms of Parkinson’s vary from person to person and can include tremor, rigidity, slowness of movement; difficulty with balance, swallowing, chewing, and speaking; and cognitive dysfunction, including dementia, depression, anxiety disorder, insomnia, and attention difficulties.
- There is no cure, therapy, or drug to slow or stop the progression of Parkinson’s disease, with disease progression leading to severe disability and possible confinement to a wheelchair or bed.
- Local, regional, and state volunteers, researchers, and clinicians are working together to improve the quality of life of the affected individuals with Parkinson’s disease and their families. Increased education and promoting research is needed to find the cause, more effective treatment, and a cure for Parkinson’s disease.
- Better awareness and expanded knowledge of the realities of life with Parkinson’s disease and its impact on patients’ lives will help give hope for a better future for people with Parkinson’s disease.
FISCAL EFFECT: None
REGISTERED SUPPORT / OPPOSITION:
Support
None on file
Opposition
None on file
Analysis Prepared by: Nicole Willis / RLS. / (916) 319-2800
Bill Author
Bill Co-Author(s):